3,3-Dimethyl-1-butanol

Last updated
3,3-Dimethyl-1-butanol
3,3-Dimethyl-1-butanol.svg
Names
Preferred IUPAC name
3,3-Dimethylbutan-1-ol
Other names
3,3-Dimethyl-1-butanol
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.009.884 OOjs UI icon edit-ltr-progressive.svg
PubChem CID
UNII
  • InChI=1S/C6H14O/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3
    Key: DUXCSEISVMREAX-UHFFFAOYSA-N
  • InChI=1/C6H14O/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3
    Key: DUXCSEISVMREAX-UHFFFAOYAW
  • CC(C)(C)CCO
Properties
C6H14O
Molar mass 102.177 g·mol−1
Density 0.844 g/cm3 (15 °C)
Melting point −60 °C (−76 °F; 213 K)
Boiling point 143 °C (289 °F; 416 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

3,3-Dimethyl-1-butanol (DMB) is a structural analog of choline. [1]

Contents

Effects

DMB inhibits microbial trimethylamine (TMA) formation in mice and in human feces, thereby reducing plasma trimethylamine N-oxide (TMAO) levels after choline or carnitine supplementation. [1] It consequently inhibited choline-enhanced endogenous macrophage foam cell formation and atherosclerotic lesion development in mice without alterations in circulating cholesterol levels. [1]

While mice placed on a choline supplemented diet showed an increase in the proportions of the bacterial taxon Clostridiales in the gut, DMB induced a decrease in the proportions of this taxon. [1]

Mice showed no evidence of toxicity to chronic (16-week) DMB exposure. [1] [2]

Occurrence

DMB is found in some balsamic vinegars, red wines, and some cold-pressed extra virgin olive oils and grape seed oils. [1]

References

  1. 1 2 3 4 5 6 Wang, Zeneng; Roberts, Adam B.; Buffa, Jennifer A.; Levison, Bruce S.; Zhu, Weifei; Org, Elin; Gu, Xiaodong; Huang, Ying; Zamanian-Daryoush, Maryam; Culley, Miranda K.; DiDonato, Anthony J.; Fu, Xiaoming; Hazen, Jennie E.; Krajcik, Daniel; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L. (December 2015). "Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis". Cell. 163 (7): 1585–1595. doi:10.1016/j.cell.2015.11.055. PMC   4871610 . PMID   26687352.
  2. EP0081050A1,Kaufhold, Manfred Dr,"Process for the production of pure neohexanol",issued 1983-06-15